Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) President Jon Christianson sold 1,991 shares of the firm’s stock in a transaction dated Wednesday, January 28th. The stock was sold at an average price of $119.88, for a total value of $238,681.08. Following the sale, the president owned 62,985 shares of the company’s stock, valued at $7,550,641.80. The trade was a 3.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Jon Christianson also recently made the following trade(s):
- On Tuesday, December 23rd, Jon Christianson sold 1,691 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total transaction of $235,894.50.
- On Tuesday, November 18th, Jon Christianson sold 522 shares of Palomar stock. The shares were sold at an average price of $128.84, for a total transaction of $67,254.48.
Palomar Price Performance
Palomar stock traded up $0.38 during trading hours on Friday, hitting $123.59. The company had a trading volume of 266,025 shares, compared to its average volume of 191,596. Palomar Holdings, Inc. has a fifty-two week low of $104.47 and a fifty-two week high of $175.85. The firm has a market capitalization of $3.28 billion, a P/E ratio of 19.28 and a beta of 0.42. The firm’s fifty day moving average is $127.64 and its 200-day moving average is $124.07.
Hedge Funds Weigh In On Palomar
Institutional investors have recently made changes to their positions in the business. Royal Bank of Canada boosted its stake in Palomar by 49.1% during the 1st quarter. Royal Bank of Canada now owns 2,956 shares of the company’s stock valued at $406,000 after purchasing an additional 974 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Palomar by 5.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,427 shares of the company’s stock valued at $2,115,000 after acquiring an additional 791 shares during the period. NewEdge Advisors LLC acquired a new stake in shares of Palomar in the first quarter worth $66,000. United Services Automobile Association bought a new position in Palomar during the first quarter worth $223,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Palomar by 11.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 72,661 shares of the company’s stock valued at $9,960,000 after purchasing an additional 7,754 shares during the last quarter. 90.25% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
PLMR has been the topic of several recent research reports. Weiss Ratings raised shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price objective on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Wall Street Zen raised shares of Palomar from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Finally, JPMorgan Chase & Co. raised their target price on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Six analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $159.50.
Get Our Latest Report on Palomar
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Featured Stories
- Five stocks we like better than Palomar
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- End of America update
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- What a Former CIA Agent Knows About the Coming Collapse
- Buy This Stock at 9:30 AM on MONDAY!
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
